A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Induction and Donor Specific Antibodies in Low Immunologic Risk Kidney Transplant Recipients
2020
Kidney360
Optimal induction for patients without pretransplant donor-specific antibodies (DSAs) is poorly defined. The goal of this study was to compare the incidence of de novo DSA (dnDSA) and graft outcomes between induction therapies in patients with a negative virtual crossmatch (VXM). A retrospective chart review was performed, identifying 782 patients with a negative VXM who underwent kidney transplantation at a single, high-volume institution between January 2013 and May 2017. Kaplan-Meier
doi:10.34067/kid.0000122020
pmid:35372884
pmcid:PMC8815535
fatcat:xk6tyrh4abbipgbaikf4k6sxsy